173 related articles for article (PubMed ID: 23103602)
1. Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment.
Haney JT; Erraguntla N; Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2012 Dec; 64(3):466-80. PubMed ID: 23103602
[TBL] [Abstract][Full Text] [Related]
2. Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches.
Proctor DM; Bhat V; Suh M; Reichert H; Jiang X; Thompson CM
Regul Toxicol Pharmacol; 2021 Aug; 124():104969. PubMed ID: 34089813
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
4. Consideration of non-linear, non-threshold and threshold approaches for assessing the carcinogenicity of oral exposure to hexavalent chromium.
Haney J
Regul Toxicol Pharmacol; 2015 Dec; 73(3):834-52. PubMed ID: 26493004
[TBL] [Abstract][Full Text] [Related]
5. Development of an inhalation unit risk factor for hexavalent chromium.
Haney JT; Erraguntla N; Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2014 Mar; 68(2):201-11. PubMed ID: 24361343
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
7. A search for thresholds and other nonlinearities in the relationship between hexavalent chromium and lung cancer.
Park RM; Stayner LT
Risk Anal; 2006 Feb; 26(1):79-88. PubMed ID: 16492182
[TBL] [Abstract][Full Text] [Related]
8. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
Gaylor DW; Swirsky Gold L
Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
[TBL] [Abstract][Full Text] [Related]
9. Implications of dose-dependent target tissue absorption for linear and non-linear/threshold approaches in development of a cancer-based oral toxicity factor for hexavalent chromium.
Haney J
Regul Toxicol Pharmacol; 2015 Jul; 72(2):194-201. PubMed ID: 25910675
[TBL] [Abstract][Full Text] [Related]
10. Human health risk and exposure assessment of chromium (VI) in tap water.
Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
[TBL] [Abstract][Full Text] [Related]
11. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
[TBL] [Abstract][Full Text] [Related]
12. Approaches to cancer assessment in EPA's Integrated Risk Information System.
Gehlhaus MW; Gift JS; Hogan KA; Kopylev L; Schlosser PM; Kadry AR
Toxicol Appl Pharmacol; 2011 Jul; 254(2):170-80. PubMed ID: 21034767
[TBL] [Abstract][Full Text] [Related]
13. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
14. Need for improved science in standard setting for hexavalent chromium.
Proctor DM; Panko JM; Finley BL; Butler WJ; Barnhart RJ
Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):99-101. PubMed ID: 10341141
[No Abstract] [Full Text] [Related]
15. Development of linear and threshold no significant risk levels for inhalation exposure to titanium dioxide using systematic review and mode of action considerations.
Thompson CM; Suh M; Mittal L; Wikoff DS; Welsh B; Proctor DM
Regul Toxicol Pharmacol; 2016 Oct; 80():60-70. PubMed ID: 27233922
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
17. Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water.
Sedman RM; Beaumont J; McDonald TA; Reynolds S; Krowech G; Howd R
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006 Apr; 24(1):155-82. PubMed ID: 16690539
[TBL] [Abstract][Full Text] [Related]
18. A response to "A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure".
Proctor DM; Thompson CM; Suh M; Harris MA
Environ Res; 2011 Apr; 111(3):468-70; discussion 471-2. PubMed ID: 21316655
[No Abstract] [Full Text] [Related]
19. Risk estimation for carcinogens based on epidemiological data: a structured approach, illustrated by an example on chromium.
Goldbohm RA; Tielemans EL; Heederik D; Rubingh CM; Dekkers S; Willems MI; Dinant Kroese E
Regul Toxicol Pharmacol; 2006 Apr; 44(3):294-310. PubMed ID: 16497421
[TBL] [Abstract][Full Text] [Related]
20. Workplace airborne hexavalent chromium concentrations for the Painesville, Ohio, chromate production plant (1943-1971).
Proctor DM; Panko JP; Liebig EW; Scott PK; Mundt KA; Buczynski MA; Barnhart RJ; Harris MA; Morgan RJ; Paustenbach DJ
Appl Occup Environ Hyg; 2003 Jun; 18(6):430-49. PubMed ID: 12746066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
